Multivariable regression analysis of perioperative parameters for a novel pulsed solid-state Thulium: YAG laser with high peak power versus Holmium: YAG laser in prostate enucleation - Scorecard - MDSpire

Multivariable regression analysis of perioperative parameters for a novel pulsed solid-state Thulium: YAG laser with high peak power versus Holmium: YAG laser in prostate enucleation

  • By

  • M. F. von Bargen

  • M. Glienke

  • S. Tonyali

  • A. Sigle

  • K. Wilhelm

  • M. Schoenthaler

  • C. Gratzke

  • A. Miernik

  • July 26, 2025

  • 0 min

Share

Clinical Scorecard: Analysis of Perioperative Factors Using Multivariable Regression for a New High-Peak Power Pulsed Solid-State Thulium: YAG Laser Compared to Holmium: YAG Laser in Prostate Enucleation

At a Glance

CategoryDetail
ConditionBenign prostatic hyperplasia (BPH) causing bladder outlet obstruction
Key MechanismsLaser enucleation of the prostate using pulsed solid-state Thulium: YAG laser versus Holmium: YAG laser
Target PopulationMen with BPH refractory to medical treatment, including those with refractory urinary retention or hematuria
Care SettingSurgical urology setting performing endoscopic enucleation of the prostate

Key Highlights

  • Pulsed solid-state Thulium: YAG laser has higher peak power (3,700 W) and wavelength (2013 nm) close to water absorption peak, enabling efficient tissue ablation with less penetration and damage than Holmium: YAG laser.
  • Laser enucleation of the prostate (LEP) is recommended over TURP due to lower bleeding risk and shorter hospitalization.
  • Both HoLEP and pulsed ThuLEP performed with en-bloc technique by experienced surgeons using standardized protocols including monopolar electrocautery for hemostasis.

Guideline-Based Recommendations

Diagnosis

  • Diagnosis of BPH causing bladder outlet obstruction confirmed by clinical symptoms, prostate volume measurement, PSA levels, and uroflowmetry.

Management

  • Endoscopic enucleation of the prostate (EEP) is standard surgical treatment regardless of prostate size.
  • Laser enucleation (HoLEP or pulsed ThuLEP) preferred due to lower bleeding risk and shorter hospital stay compared to TURP.
  • Antiplatelet therapy with aspirin may be continued; clopidogrel paused 7 days preoperatively; anticoagulants paused or bridged as per protocol.

Monitoring & Follow-up

  • Perioperative monitoring includes duration of surgery, enucleation time, laser energy used, enucleated tissue weight, catheterization duration, hospitalization length, and postoperative pain scores.
  • Postoperative follow-up up to 30 days to assess complications and recovery.

Risks

  • Potential bleeding controlled by monopolar electrocautery post-enucleation.
  • Management of anticoagulants and antiplatelet agents to minimize bleeding risk.

Patient & Prescribing Data

Men with symptomatic BPH refractory to medical therapy undergoing surgical enucleation.

Pulsed solid-state Thulium: YAG laser offers efficient ablation with less tissue damage and charring compared to Holmium: YAG laser, potentially improving perioperative outcomes.

Clinical Best Practices

  • Use of standardized en-bloc enucleation technique by experienced surgeons.
  • Preoperative management of antiplatelet and anticoagulant therapies according to institutional protocols.
  • Application of monopolar electrocautery for hemostasis after laser enucleation.
  • Use of continuous bladder irrigation postoperatively with three-way urinary catheter.

References

Original Source(s)

Related Content